News
15.June 10Longbow Newsletter Summer 2010Please click here to read our latest newsletter.


26.May 10Budget changes to CGT: Watch this space...Click here to be added to our Budget update mailing list.


15.March 10Ambicare on Sky NewsRead more on Ambicare’s new product, the Ambulight, at Sky.com and watch the Sky News reports online.

Further coverage has also been achieved across the UK media and overseas. Click here to read further information at the Longbow Capital Blog.




10.March 10Julian Hickman writes for Investment AdviserJulian Hickman, Longbow Partner, has been featured in Investment Adviser this week writing on EIS investment. Read the article entitled ’Focus: Enterprise worth investigating’ by clicking the link below.

Investment Adviser


10.March 10Read reviews about the Longbow EIS FundsReviews on Longbow’s EIS Funds are now available in Martin Churchill’s Tax Efficient Review and Allenbridge’s Tax Shelter Report.


17.February 10Takeda invests in DomainexClick here to read the latest news from Domainex.


17.February 10Longbow Newsletter February 2010Please click here to read Longbow’s latest newsletter.


10.February 10Longbow Approved EIS Fund LaunchThe announcement of the launch of our latest Fund, the Longbow Approved EIS Fund 2010 has generated significant coverage in the IFA press.

Click on the links below to read more.

Private Equity Wire

Unquote

Fund Strategy


Investment Adviser



05.February 10Longbow Launches Approved EIS Fund 2010Please click here to read the press release.


28.January 10Read our blogLongbow has recently launched a blog.

Click here to read articles, discussions and the latest news from Longbow Capital.


19.October 09Longbow Newsletter Autumn 2009Please click here to read our latest newsletter.


28.September 09Breastlight in BootsThe Breastlight is now on sale in Boots stores and online at www.boots.com.

This follows a successful launch in Canada through Rexall, the leading Canadian pharmacy chain.

The device has received an impressive amount of press coverage in recent weeks and has been seen in Good Housekeeping, Health & Fitness, More Magazine, Women’s Own and most recently in Cosmopolitan.


28.September 09Longbow invests in Calon Cardio TechnologyLongbow is pleased to announce that we have completed an investment into Calon Cardio Technology, a developer of novel heart pumps.

Calon Cardio’s designs are unique in that they can be implanted using minimally invasive procedures rather than open heart surgery.


25.September 09Ambicare recieves CE markingLongbow portfolio company Ambicare has achieved CE marking for its lead product the ’Ambulight, which treats non melanoma skin cancer. It can now actively market its product in the European Union.


20.September 09Lumicure changes name to AmbicareLongbow portfolio company Lumicure Ltd, which is developing light-based treatments for skin cancer and acne, has changed its name to Ambicare.
Ambicare has recently completed development of its lead product (Ambulight) for the treatment of non melanoma skin cancer.


14.September 09Polytherics collaborates with MinapharmLongbow portfolio company PolyTherics Limited today announced the initiation of a research collaboration agreement with Minapharm Pharmaceuticals, the leading Egyptian pharmaceutical company. PolyTherics will apply its proprietary drug modification technologies to a target protein of commercial interest to Minapharm.


01.September 09Biotronics opens Innovation CentreBiotronics3D has opened an Innovation Centre in Cambridge, UK to boost its research and development capabilities. The strategic location next to a world leading academic institution and in the heart of several unique medical technology clusters will allow the company to accelerate the development of novel components for its future products.


First name:
Last name:
Work email:
Company:
Your Question/Request:
 
 
Your privacy is important to us.
Visit the Longbow BlogJoin the discussion
For real time updates from the portfolio companies, articles, photos and videos visit the
Longbow Capital Blog.